International Clinical Trial: Safety and Tolerability Evaluation of IgG Binding Protein LT

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824011) titled 'Safety and Tolerability Evaluation of IgG Binding Protein LT' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Bactolife A/S

Condition: Safety and Tolerability in Healthy Volunteers

Intervention: Dietary Supplement: IgG Binding Protein LT

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2026

Target Sample Size: 40

Countries of Recruitment: United States

To know more, visit https://clinicaltrials...